Intensive Prevention Program After Myocardial Infarction

Exclusion Criteria

• •i) Hemodynamically significant valvular heart disease (\> NYHA class II) or inborn cardiac malformations.
• •ii) Cardiomyopathy associated with hemodynamic obstruction, pregnancy or myocarditis.
• •iii) Exercise limitations due to clinical conditions not related to CAD. iv) Any major non-cardiac condition that would adversely effect survival during the duration of the study.
• •v) Patients unlikely to comply to the study treatment and the follow-up visits. vi) Pregnancy (all pre-menopausal females should have a negative serum pregnancy test).
• •vii) Inability of cooperation with the protocol, including longterm follow-up. viii) Patient refusal or inability to give informed consent. ix) Refusal of the patient's physician regarding trial participation of the patient.
• •x) Chronic drug or alcohol abuse.